OCUL OCULAR THERAPEUTIX, INC
Nasdaq · SEC CIK 1393434 · EDGAR
- Bought, last 12 months
- $461.4K 1 purchases by 1 insiders
- Sold, last 12 months
- $3.42M 28 sales by 8 insiders
- Filings on record
- 160 since 2021-08-24, latest 2026-09-02 16:01
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Dugel Pravin | See Remarks, Dir | — | $1.94M |
| LINDSTROM RICHARD L MD | Dir | $461.4K | — |
| Saroj Namrata | Chief Business Off | — | $277.8K |
| Heier Jeffrey S. | CSO | — | $243.3K |
| Kaiser Peter | Chief Development Off | — | $222.9K |
| Waheed Nadia | Chief Medical Off | — | $220.9K |
| Notman Donald | See Remarks | — | $216.1K |
| Nayak Sanjay | Chief Strategy Off | — | $166.4K |
| Anderman Todd | CLO | — | $137.4K |
| Robinson David Wayne | Gbl CCO | — | — |
Transactions 166
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-04 | 2024-06-01 | OCUL | Waheed Nadia | Chief Medical Off | A - Grant | $0.00 | +141.7K | 141.7K | New | $0 |
| 2024-05-28 | 2024-05-23 | OCUL | Dugel Pravin | See Remarks, Dir | S - Sale | $5.79 | -21.6K | 833.4K | -3% | -$125.2K | |
| 2024-05-28 | 2024-05-23 | OCUL | Nayak Sanjay | Chief Strategy Off | S - Sale | $5.84 | -2,274 | 178.0K | -1% | -$13.3K | |
| I | 2024-02-27 | 2024-02-26 | OCUL | SUMMER ROAD LLC | 10% | P - Purchase | $7.52 | +930.9K | 8.59M | +12% | +$7.00M |
| D | 2024-02-26 | 2024-02-22 | OCUL | Dugel Pravin | Executive COB, Dir | A - Grant | $0.00 | +855.0K | 855.0K | New | $0 |
| D | 2024-02-26 | 2024-02-22 | OCUL | Nayak Sanjay | Chief Strategy Off | A - Grant | $0.00 | +80.3K | 180.3K | +80% | $0 |
| D | 2024-02-06 | 2024-02-03 | OCUL | Strassburger Philip C. | GC | A - Grant | $0.00 | +58.3K | 167.5K | +53% | $0 |
| D | 2024-02-06 | 2024-02-05 | OCUL | Strassburger Philip C. | GC | S - Sale | $4.86 | +6,029 | 161.5K | +4% | +$29.3K |
| D | 2024-02-06 | 2024-02-03 | OCUL | Notman Donald | CFO | A - Grant | $0.00 | +61.6K | 201.6K | +44% | $0 |
| D | 2024-02-06 | 2024-02-05 | OCUL | Notman Donald | CFO | S - Sale | $4.86 | +6,212 | 195.4K | +3% | +$30.2K |
| D | 2024-02-06 | 2024-02-05 | OCUL | Mattessich Antony C. | Pres, CEO, Dir | S - Sale | $4.86 | +19.6K | 588.7K | +3% | +$95.5K |
| D | 2024-02-06 | 2024-02-03 | OCUL | Mattessich Antony C. | Pres, CEO, Dir | A - Grant | $0.00 | +180.4K | 608.3K | +42% | $0 |
| D | 2024-02-06 | 2024-02-05 | OCUL | Ozden Rabia Gurses | Chief Medical Off | S - Sale | $4.86 | +6,346 | 153.1K | +4% | +$30.8K |
| D | 2024-02-06 | 2024-02-03 | OCUL | Ozden Rabia Gurses | Chief Medical Off | A - Grant | $0.00 | +66.6K | 159.4K | +72% | $0 |
| D | 2024-02-06 | 2024-02-03 | OCUL | White Christopher G | Chief Business Off | A - Grant | $0.00 | +40.0K | 129.6K | +45% | $0 |
| D | 2024-02-06 | 2024-02-05 | OCUL | White Christopher G | Chief Business Off | S - Sale | $4.86 | +5,910 | 123.7K | +5% | +$28.7K |
| 2024-02-02 | 2024-01-31 | OCUL | White Christopher G | Chief Business Off | S - Sale | $4.95 | -5,147 | 89.6K | -5% | -$25.5K | |
| 2024-02-02 | 2024-01-31 | OCUL | Ozden Rabia Gurses | Chief Medical Off | S - Sale | $4.95 | -7,764 | 92.8K | -8% | -$38.4K | |
| 2024-02-02 | 2024-01-31 | OCUL | Strassburger Philip C. | GC | S - Sale | $4.95 | -6,831 | 109.2K | -6% | -$33.8K | |
| 2024-02-02 | 2024-01-31 | OCUL | Mattessich Antony C. | Pres, CEO, Dir | S - Sale | $4.95 | -18.3K | 427.9K | -4% | -$90.8K | |
| 2024-02-02 | 2024-01-31 | OCUL | Notman Donald | CFO | S - Sale | $4.95 | -6,433 | 139.9K | -4% | -$31.8K | |
| I | 2023-12-18 | 2023-12-14 | OCUL | SUMMER ROAD LLC | 10% | P - Purchase | $3.25 | +1.54M | 7.66M | +25% | +$5.00M |
| I | 2023-09-05 | 2023-08-30 | OCUL | Mattessich Antony C. | Pres, CEO, Dir | P - Purchase | $3.81 | +6,500 | 6,500 | New | +$24.8K |
| D | 2023-07-12 | 2023-07-10 | OCUL | Graves Adrienne L | Dir | A - Grant | $0.00 | +24.0K | 24.0K | New | $0 |
| 2023-07-11 | 2023-07-07 | OCUL | Ozden Rabia Gurses | Chief Medical Off | S - Sale | $4.93 | -832 | 100.5K | -0.8% | -$4,102 | |
| D | 2023-06-16 | 2023-06-14 | OCUL | Hong Seung Suh | Dir | A - Grant | $0.00 | +12.0K | 20.9K | +134% | $0 |
| D | 2023-06-16 | 2023-06-14 | OCUL | Heier Jeffrey S. | Dir | A - Grant | $0.00 | +12.0K | 59.9K | +25% | $0 |
| D | 2023-06-16 | 2023-06-14 | OCUL | Warden Charles M | Dir | A - Grant | $0.00 | +12.0K | 60.5K | +25% | $0 |
| D | 2023-06-16 | 2023-06-14 | OCUL | RAINES MERILEE | Dir | A - Grant | $0.00 | +12.0K | 20.9K | +134% | $0 |
| D | 2023-06-16 | 2023-06-14 | OCUL | LINDSTROM RICHARD L MD | Dir | A - Grant | $0.00 | +12.0K | 120.4K | +11% | $0 |
| D | 2023-06-16 | 2023-06-14 | OCUL | Williams Leslie J. | Dir | A - Grant | $0.00 | +12.0K | 25.4K | +89% | $0 |
| 2023-02-08 | 2023-02-06 | OCUL | White Christopher G | Chief Business Off | S - Sale | $4.24 | -5,829 | 94.8K | -6% | -$24.7K | |
| 2023-02-08 | 2023-02-06 | OCUL | Ozden Rabia Gurses | Chief Medical Off | S - Sale | $4.24 | -6,416 | 101.4K | -6% | -$27.2K | |
| 2023-02-08 | 2023-02-06 | OCUL | Notman Donald | CFO | S - Sale | $4.24 | -6,476 | 139.4K | -4% | -$27.5K | |
| 2023-02-08 | 2023-02-06 | OCUL | Strassburger Philip C. | GC | S - Sale | $4.24 | -6,181 | 109.1K | -5% | -$26.2K | |
| 2023-02-08 | 2023-02-06 | OCUL | Mattessich Antony C. | Pres, CEO, Dir | S - Sale | $4.24 | -19.7K | 446.3K | -4% | -$83.4K | |
| D | 2023-02-01 | 2023-01-30 | OCUL | Mattessich Antony C. | Pres, CEO, Dir | A - Grant | $0.00 | +176.3K | 465.9K | +61% | $0 |
| D | 2023-02-01 | 2023-01-30 | OCUL | Ozden Rabia Gurses | Chief Medical Off | A - Grant | $0.00 | +55.6K | 107.8K | +106% | $0 |
| D | 2023-02-01 | 2023-01-30 | OCUL | Notman Donald | CFO | A - Grant | $0.00 | +55.6K | 145.9K | +62% | $0 |
| D | 2023-02-01 | 2023-01-30 | OCUL | White Christopher G | Chief Business Off | A - Grant | $0.00 | +44.4K | 100.6K | +79% | $0 |
| D | 2023-02-01 | 2023-01-30 | OCUL | Strassburger Philip C. | GC | A - Grant | $0.00 | +55.6K | 115.3K | +93% | $0 |
| I | 2022-11-09 | 2022-11-07 | OCUL | SUMMER ROAD LLC | 10% | P - Purchase | $3.50 | +7,328 | 6.12M | +0.1% | +$25.6K |
| MI | 2022-10-12 | 2022-10-10+ | OCUL | SUMMER ROAD LLC | 10% | P - Purchase | $3.95 | +20.0K | 6.10M | +0.3% | +$79.0K |
| MI | 2022-09-29 | 2022-09-27+ | OCUL | SUMMER ROAD LLC | 10% | P - Purchase | $4.60 | +150.0K | 6.09M | +3% | +$689.3K |
| D | 2022-07-15 | 2022-07-01 | OCUL | Ozden Rabia Gurses | Chief Medical Off | A - Grant | $0.00 | +6,667 | 52.2K | +15% | $0 |
| D | 2022-06-21 | 2022-06-16 | OCUL | LINDSTROM RICHARD L MD | Dir | A - Grant | $0.00 | +8,933 | 108.4K | +9% | $0 |
| D | 2022-06-21 | 2022-06-16 | OCUL | Heier Jeffrey S. | Dir | A - Grant | $0.00 | +8,933 | 47.9K | +23% | $0 |
| D | 2022-06-21 | 2022-06-16 | OCUL | Hong Seung Suh | Dir | A - Grant | $0.00 | +8,933 | 8,933 | New | $0 |
| D | 2022-06-21 | 2022-06-16 | OCUL | Warden Charles M | Dir | A - Grant | $0.00 | +8,933 | 48.5K | +23% | $0 |
| D | 2022-06-21 | 2022-06-16 | OCUL | RAINES MERILEE | Dir | A - Grant | $0.00 | +8,933 | 8,933 | New | $0 |
| D | 2022-06-21 | 2022-06-16 | OCUL | Williams Leslie J. | Dir | A - Grant | $0.00 | +8,933 | 13.4K | +199% | $0 |
| D | 2022-05-16 | 2022-05-12 | OCUL | LINDSTROM RICHARD L MD | Dir | M - OptEx | $1.22 | +9,469 | 99.5K | +11% | +$11.6K |
| 2022-05-16 | 2022-05-12 | OCUL | Heier Jeffrey S. | Dir | P - Purchase | $3.05 | +15.0K | 39.0K | +62% | +$45.8K | |
| MI | 2022-02-23 | 2022-02-18+ | OCUL | SUMMER ROAD LLC | 10% | P - Purchase | $4.96 | +50.0K | 5.93M | +0.8% | +$248.0K |
| D | 2022-02-07 | 2022-02-03 | OCUL | Strassburger Philip C. | GC | A - Grant | $0.00 | +50.0K | 51.8K | +2,762% | $0 |
| D | 2022-02-07 | 2022-02-03 | OCUL | Goldstein Michael H. | Pres, CMO, Ophthalmology | A - Grant | $0.00 | +63.3K | 313.3K | +25% | $0 |
| D | 2022-02-07 | 2022-02-03 | OCUL | Mattessich Antony C. | Pres, CEO | A - Grant | $0.00 | +186.8K | 289.6K | +181% | $0 |
| D | 2022-02-07 | 2022-02-03 | OCUL | White Christopher G | Chief Business Off | A - Grant | $0.00 | +50.0K | 52.1K | +2,351% | $0 |
| D | 2022-02-07 | 2022-02-03 | OCUL | Notman Donald | CFO | A - Grant | $0.00 | +55.6K | 81.6K | +213% | $0 |
| MI | 2022-01-31 | 2022-01-27+ | OCUL | SUMMER ROAD LLC | 10% | P - Purchase | $5.20 | +5,500 | 5.89M | +0.1% | +$28.6K |
| MI | 2022-01-24 | 2022-01-20+ | OCUL | SUMMER ROAD LLC | 10% | P - Purchase | $5.44 | +74.5K | 5.84M | +1% | +$405.6K |
| MI | 2022-01-18 | 2022-01-13+ | OCUL | SUMMER ROAD LLC | 10% | P - Purchase | $6.06 | +50.0K | 5.81M | +0.9% | +$303.0K |
| MI | 2021-12-16 | 2021-12-14+ | OCUL | SUMMER ROAD LLC | 10% | P - Purchase | $6.35 | +44.5K | 5.76M | +0.8% | +$282.3K |
| MI | 2021-12-14 | 2021-12-10+ | OCUL | SUMMER ROAD LLC | 10% | P - Purchase | $6.61 | +40.5K | 5.71M | +0.7% | +$267.8K |
| MI | 2021-12-08 | 2021-12-06+ | OCUL | SUMMER ROAD LLC | 10% | P - Purchase | $6.18 | +60.9K | 5.68M | +1% | +$376.6K |
| 2021-08-24 | 2021-08-20 | OCUL | Mattessich Antony C. | Pres, CEO, Dir | P - Purchase | $9.89 | +5,000 | 102.9K | +5% | +$49.5K |
Purchase Sale Sale after option exercise All abbreviations